Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362Phase 2Completed
- Sponsor
- Emory University
- Start
- Nov 2019
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triamcinolone in asthma, sponsored by Emory University. Primary endpoint: Asthma Control Questionnaire at Day 14. Started Nov 2019; status: completed.
02
Drugs
triamcinolone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04002362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002362.